Barclays
ELX

Barclays’s EMULEX CORP ELX Stock Holding History

Barclays’s Portfolio ELX Stock Details ELX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,300
Closed -$72K – 7477
2015
Q1 		$72K Buy
10,300
+5,000
+94% +$35K ﹤0.01% 5048
2014
Q4 		$27K Sell
5,300
-142,500
-96% -$768K ﹤0.01% 6151
2014
Q3 		$591K Buy
147,800
+2,000
+1% +$10.8K ﹤0.01% 3814
2014
Q2 		$729K Buy
145,800
+143,400
+5,975% +$853K ﹤0.01% 3631
2014
Q1 		$17K Sell
2,400
-16,600
-87% -$122K ﹤0.01% 6695
2013
Q4 		$133K Buy
19,000
+100
+0.5% +$742 ﹤0.01% 5396
2013
Q3 		$132K Buy
18,900
+12,300
+186% +$95.6K ﹤0.01% 5405
2013
Q2 		$43K Buy
+6,600
New +$41.5K ﹤0.01% 6416

Barclays's ELX Position: Q2 2015 in Review

Barclays sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 791,734 shares — an estimated $5.54M sold.

Barclays first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $5.54M in Q1 2015. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Barclays reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Barclays sold 791,734 EMULEX CORP shares in Q2 2015, an estimated $5.54M.
  • Barclays first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Barclays's EMULEX CORP position peaked at $5.54M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.